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Abstract
Alzheimer’s disease and other neurodegenerative disorders of aging are characterized by clinical and pathological features
that are relatively specific to humans. To obtain greater insight into how brain aging has evolved, we compared age-related
gene expression changes in the cortex of humans, rhesus macaques, and mice on a genome-wide scale. A small subset of
gene expression changes are conserved in all three species, including robust age-dependent upregulation of the
neuroprotective gene apolipoprotein D (APOD) and downregulation of the synaptic cAMP signaling gene calcium/
calmodulin-dependent protein kinase IV (CAMK4). However, analysis of gene ontology and cell type localization shows that
humans and rhesus macaques have diverged from mice due to a dramatic increase in age-dependent repression of
neuronal genes. Many of these age-regulated neuronal genes are associated with synaptic function. Notably, genes
associated with GABA-ergic inhibitory function are robustly age-downregulated in humans but not in mice at the level of
both mRNA and protein. Gene downregulation was not associated with overall neuronal or synaptic loss. Thus, repression of
neuronal gene expression is a prominent and recently evolved feature of brain aging in humans and rhesus macaques that
may alter neural networks and contribute to age-related cognitive changes.
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Introduction
Aging is the primary risk factor for Alzheimer’s disease and
other prevalent neurodegenerative disorders [1,2]. Little is known,
however, about the degree to which normal brain aging is
conserved among mammalian species, an issue of central
importance in the biology of aging and the development of
animal models of human neurological diseases [3]. Gene
expression changes that appear during normal brain aging have
been explored using microarrays that interrogate only part of the
genome in a number of species, including mice, rats, monkeys, and
humans [4,5,6,7]. Comparison of the partial expression profiles of
the aging mouse and human brain did not show significant overlap
[8]. However, there has yet to be a systematic comparison of gene
expression at a genome-wide scale in aging mice, monkeys, and
humans. Recent advances in sequencing the rhesus macaque,
mouse, and human genomes have enabled us to perform a
genome-scale comparative analysis of gene expression in the aging
mammalian brain [9,10,11,12]. Although a small subset of age-
related gene expression changes are conserved from mouse to
man, major changes in the expression of genes involved in
neurotransmission have evolved in the primate cortex that are
potentially relevant to age-related changes in cognition and
vulnerability to neurodegeneration.
Results
Phylogenetic Analysis of Brain Aging in Humans, Rhesus
Macaques, and Mice
A central issue in a cross-species comparative analysis of aging is
the identification of similar aging groups in species with very
different maximal life spans. We previously defined the expression
profile for age-related expression changes in the human cortex and
demonstrated that these changes occur in the majority of
individuals by the age of 70 years [6]. We used this expression
profile as the basis for defining our aged group in humans as
individuals older than 70 years of age who were not diagnosed
with a neurodegenerative disorder (Table S1). To identify a similar
age group in mice, we used comparative survival curves for
humans and mice which suggest that a 30-month-old mouse is
similar to an 81-year-old human since at these ages approximately
25% of the original populations survive. A similar survival analysis
in rhesus monkeys in captivity determined that 25% survival
occurred at approximately 26 years of age [13]. Hence, we chose
30 months and 28–31 years as the aged groups for mice and rhesus
monkeys, respectively.
To identify age-related changes in gene expression, cortical
samples from 13 young (#40 years old) and 15 aged ($70 years
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5-month-old (n=5) and 30-month-old mice (n=5) were hybrid-
ized to Affymetrix Mouse 430 2.0 arrays, and samples from 5–6-
year-old (n=5) and 28–31-year-old (n=6) rhesus macaques were
hybridized to Affymetrix whole genome rhesus arrays. Since the
rhesus macaque genome has only recently been sequenced [9], the
rhesus microarrays are based primarily on gene predictions.
Therefore, we used an all-against-all protein BLAST to identify
orthologous genes between the rhesus predictions and the other two
species. For each homolog pair, we required a BLAST score of
greaterthan200,andatleast80%alignment of the humanormouse
proteinsequencewiththe rhesussequence(TableS2).The finalgene
set was composed of genes that possess an ortholog in every species
and are represented on all three array platforms. We then employed
a two-sample t-test between young and aged age groups with a 1%
false discovery rate (FDR) cut-off to identify 3542, 573, and 2347
age-related genesinmice, rhesus monkeys, and humans, respectively
(Tables S3–5). Among these age-related changes, only 154 were
significantly associated with aging in all three species (Fig. 1a and
Table S6). To assess this gene group as an indicator of brain aging,
the behavior of all 154 genes was compared across age groups and
species to derive Pearson correlation coefficients. The resulting
correlation matrix showed that this core gene set distinguishes
between young and aged samples in all three species (Fig. 1b).
Furthermore, this set of age-related gene expression changes
distinguished between chronological and biological age. For
example, a 30-year-old rhesus monkey more closely resembled a
70-year-old human than a 30-year-old human. This set of common
age related expression changes is therefore linked to the biology of
the aging process in the brain.
Hierarchical clustering of the common age-regulated genes
demonstrated that they fall into three distinct groups: I. Age-
regulated genes that are conserved among all three species. II.
Genes that change with age in all 3 species but differ in
directionality between mouse and rhesus (e.g., from age-downreg-
ulated to age-upregulated); and III. Age-regulated genes that
change directionality between rhesus and human (Fig. 2 and
Table 1). Among the category I genes conserved in all 3 species,
the most robustly age-upregulated gene was the anti-oxidant lipid
binding protein apolipoprotein D. The most robustly age-
downregulated genes in the conserved category were CAMK4, a
component of synaptic cAMP-mediated signaling, and ARPP-21,
a phosphoprotein also implicated in neuronal cAMP signaling [14]
(Table 1). The genes in category II were composed almost entirely
of genes that are age-upregulated in mice and downregulated in
both rhesus monkeys and humans, defining a set of age-related
gene expression changes common to rhesus monkeys and humans.
The most robustly downregulated of these primate aging genes
was calbindin 1 (CALB1), a marker of cortical inhibitory
interneurons (Table 1).
Cell-Type Enrichment of Age-Related Gene Expression
Changes
To identify the cell types in the brain that exhibit prominent
age-related changes in gene expression, we utilized the Allen Brain
Atlas [15]. This database, derived by in situ hybridization and 3-
dimensional imaging of the adult mouse brain (56 days old),
includes genes in which expression was significantly enriched in
one of five specific cell types. By combining this cell type analysis
with our mouse gene expression data, a subset of age-related gene
expression changes was localized to specific cell types. To
determine whether the mouse brain dataset predicts the cell type
distribution of these genes in the human brain, we performed
microarray analysis of isolated neurons, astrocytes, and microglial
Figure 1. Genome-wide comparison of brain aging in humans, rhesus macaques, and mice. a. Venn diagram indicating the extent of
overlap in age-related gene expression changes between the three species. The size of each circle corresponds to the number of age-related
expression changes in each species. b. A group of 154 common aging genes provides an indicator of biological aging in all three species. Shown is a
matrix of Pearson correlation coefficients that indicate the degree of overall similarity between any two samples (see Methods). Positively correlated
sample pairs are indicated by red and negatively correlated pairs are indicated by blue. The degree of correlation correlates with color intensity. The
species and age groups are indicated (Human: young #40 years; aged $70 years. Rhesus macaque: young 5–6 years; aged 28–31 years. Mouse:
young 5 months; aged 30 months).
doi:10.1371/journal.pone.0003329.g001
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regulated in all three species were analyzed by hierarchical clustering. Reduced expressed with aging is indicated by a transition from red in the
young to blue in the aged, and vice versa. Genes separate into three groups based on whether the direction of age-related changes (i.e., age-
upregulated or age-downregulated) is conserved in all three species (category I), changes between mice and rhesus macaques (category II), or
changes between rhesus macaques and humans (category III). Also indicated is the evolutionary time of divergence in years for each pair of species
based on analysis of protein sequence alignments [37].
doi:10.1371/journal.pone.0003329.g002
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Gene Description Gene Symbol Q-Value (%) Fold Change
Human Rhesus Mouse Human Rhesus Mouse
I. Phylogenetically Conserved Aging Genes
apolipoprotein D APOD 0.035 0.856 0.017 2.251 4.006 2.245
G protein-coupled receptor, family C, group 5, member B GPRC5B 0.279 0.232 0.017 1.642 1.412 1.415
tripeptidyl peptidase I TPP1 0.390 0.438 0.017 1.496 1.247 1.145
ribosomal protein S9 RPS9 0.549 0.232 0.028 1.337 1.754 1.270
calnexin CANX 0.090 0.232 0.057 1.200 1.371 1.677
solute carrier family 35 (UDP-galactose transporter), member A2 SLC35A2 0.035 0.438 0.028 21.136 21.525 21.447
Cofactor required for Sp1 transcriptional activation, subunit 8, 34 kDa CRSP8 0.195 0.856 0.120 21.175 21.323 21.323
Hypothetical protein MGC29898 MGC29898 0.279 0.232 0.776 21.195 21.967 21.306
glutathione synthetase GSS 0.279 0.438 0.348 21.200 21.534 21.603
ubiquitin-conjugating enzyme E2Q (putative) 1 UBE2Q1 0.549 0.720 0.639 21.202 21.534 21.249
tRNA methyltranferase 12 homolog (S. cerevisiae) TRMT12 0.740 0.501 0.240 21.229 21.452 21.538
eukaryotic translation termination factor 1 ETF1 0.195 0.856 0.412 21.231 21.409 21.215
hypothetical protein FLJ20232 RP5-1104E15.5 0.020 0.943 0.776 21.244 21.304 21.283
dual specificity phosphatase 14 DUSP14 0.065 0.856 0.057 21.260 21.296 21.428
member RAS oncogene family RAB14 0.035 0.537 0.288 21.294 21.547 21.314
Transmembrane protein 49 TMEM49 0.020 0.943 0.017 21.299 21.535 21.613
NEDD8-conjugating enzyme UBE2F 0.020 0.534 0.288 21.300 21.467 21.119
zinc finger protein 64 homolog (mouse) ZFP64 0.090 0.856 0.348 21.304 21.623 21.508
transmembrane protein vezatin VEZT 0.020 0.943 0.288 21.318 21.608 21.293
transmembrane protein 4 TMEM4 0.020 0.537 0.120 21.351 22.788 21.307
tribbles homolog 2 (Drosophila) TRIB2 0.965 0.232 0.949 21.365 21.520 21.209
Glutamine-fructose-6-phosphate transaminase 1 GFPT1 0.035 0.639 0.949 21.385 21.600 21.923
protein disulfide isomerase family A, member 6 PDIA6 0.020 0.856 0.240 21.436 21.419 21.303
Metallophosphoesterase domain containing 1 MPPED1 0.020 0.943 0.120 21.441 21.457 21.307
armadillo repeat containing 8 ARMC8 0.195 0.438 0.057 21.454 21.472 21.331
Ribonuclease H1 RNASEH1 0.020 0.599 0.120 21.478 21.425 21.174
kelch repeat and BTB (POZ) domain containing 6 KBTBD6 0.020 0.537 0.057 21.479 21.548 21.539
Membrane-associated ring finger (C3HC4) 1 MARCH1 0.195 0.639 0.120 21.481 21.361 21.977
Acetoacetyl-CoA synthetase AACS 0.020 0.775 0.412 21.517 21.347 21.456
adrenergic, beta, receptor kinase 2 ADRBK2 0.020 0.856 0.057 21.525 22.077 21.335
golgi autoantigen, golgin subfamily a, 1 GOLGA1 0.020 0.856 0.412 21.565 21.542 21.192
transmembrane protein 14B TMEM14B 0.020 0.438 0.039 21.619 21.876 21.240
Transforming growth factor, beta receptor associated protein 1 TGFBRAP1 0.090 0.775 0.776 21.738 21.226 21.117
Cyclic AMP-regulated phosphoprotein, 21 kD ARPP-21 0.020 0.232 0.017 21.953 21.457 21.137
Calcium/calmodulin-dependent protein kinase IV CAMK4 0.020 0.438 0.193 22.174 22.111 21.560
II. Aging Genes that Diverged Between Mice and Rhesus Monkeys
calbindin 1, 28 kDa CALB1 0.020 0.880 0.348 23.722 21.629 1.281
neuronal pentraxin II NPTX2 0.020 0.880 0.017 22.340 21.815 1.323
chromobox homolog 6 CBX6 0.020 0.943 0.017 22.305 21.199 1.377
adenylate cyclase 2 (brain) ADCY2 0.020 0.856 0.193 21.973 21.264 1.109
tubulin tyrosine ligase TTL 0.020 0.599 0.057 21.964 21.527 1.198
3-hydroxy-3-methylglutaryl-Coenzyme A reductase HMGCR 0.020 0.232 0.288 21.866 21.367 1.469
hepatic leukemia factor HLF 0.020 0.639 0.017 21.851 21.250 1.337
similar to hepatocellular carcinoma-associated antigen HCA557b LOC151194 0.020 0.501 0.240 21.838 21.479 1.127
trophoblast glycoprotein TPBG 0.020 0.438 0.017 21.809 21.988 1.563
phospholipase C-like 2 PLCL2 0.020 0.375 0.017 21.770 21.566 1.163
Fusion (involved in t(12;16) in malignant liposarcoma) FUS 0.020 0.959 0.412 21.743 21.535 1.145
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protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform
(calcineurin A beta)
PPP3CB 0.020 0.720 0.039 21.725 21.074 1.202
KIAA1944 protein KIAA1944 0.020 0.232 0.949 21.687 21.673 1.169
Chromosome 18 open reading frame 1 C18orf1 0.020 0.537 0.949 21.650 21.299 1.331
phosphodiesterase 4D interacting protein (myomegalin) PDE4DIP 0.195 0.534 0.057 21.640 21.333 1.292
similar to aspartate beta hydroxylase (ASPH) ASPHD2 0.020 0.232 0.120 21.628 21.494 1.154
discs, large homolog 3 (neuroendocrine-dlg, Drosophila) DLG3 0.020 0.880 0.085 21.610 21.228 1.124
adrenergic, alpha-2A-, receptor ADRA2A 0.020 0.232 0.639 21.597 22.092 1.306
component of oligomeric golgi complex 8 COG8 0.020 0.775 0.017 21.557 21.327 1.274
protein tyrosine phosphatase, non-receptor type 3 PTPN3 0.020 0.856 0.949 21.538 21.701 1.201
Small nuclear ribonucleoprotein polypeptide A9 SNRPA1 0.020 0.943 0.146 21.528 21.217 1.250
RAS guanyl releasing protein 1 (calcium and DAG-regulated) RASGRP1 0.020 0.232 0.098 21.525 21.648 1.150
Signal-induced proliferation-associated 1 like 2 SIPA1L2 0.020 0.232 0.500 21.520 22.293 1.189
Ubiquitin carboxyl-terminal hydrolase L5 UCHL5 0.020 0.775 0.028 21.492 21.999 1.357
neuregulin 3 NRG3 0.020 0.959 0.017 21.491 21.293 1.216
tubulin, alpha 1 (testis specific) TUBA1 0.020 0.438 0.949 21.486 21.289 1.067
solute carrier family 36 (proton/amino acid symporter), member 1 SLC36A1 0.065 0.232 0.146 21.482 21.860 1.235
opsin 3 (encephalopsin, panopsin) OPN3 0.020 0.943 0.057 21.478 21.430 1.268
bicaudal D homolog 2 (Drosophila) BICD2 0.020 0.501 0.017 21.470 21.523 1.426
p21(CDKN1A)-activated kinase 7 PAK7 0.020 0.959 0.017 21.455 21.343 1.534
chromosome 21 open reading frame 5 DOPEY2 0.035 0.232 0.017 21.453 21.667 1.272
Nuclear factor I/B NFIB 0.195 0.856 0.348 21.450 21.230 1.209
membrane associated guanylate kinase, WW and PDZ domain
containing 1
MAGI1 0.020 0.639 0.500 21.450 21.364 1.167
TNF receptor-associated factor 3 TRAF3 0.279 0.232 0.776 21.447 21.498 1.112
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta SGTB 0.090 0.959 0.017 21.445 21.806 1.316
hypothetical protein FLJ20701 FLJ20701 0.020 0.720 0.146 21.442 21.208 1.175
LanC lantibiotic synthetase component C-like 2 (bacterial) LANCL2 0.020 0.639 0.639 21.440 21.380 1.113
Rho GTPase-activating protein RICS 0.065 0.880 0.240 21.437 21.507 1.141
chromosome 10 open reading frame 9 C10orf9 0.020 0.856 0.017 21.425 21.379 1.490
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 DYRK2 0.195 0.232 0.039 21.422 21.821 1.251
Zinc finger protein 148 (pHZ-52) ZNF148 0.020 0.599 0.017 21.420 21.336 1.320
similar to BcDNA:GH11415 gene product C3orf59 0.020 0.232 0.017 21.412 21.333 1.689
importin 11 IPO11 0.195 0.880 0.017 21.408 21.358 1.334
neuronal pentraxin receptor NPTXR 0.090 0.943 0.288 21.407 21.199 1.310
solute carrier family 35, member B4 SLC35B4 0.020 0.537 0.017 21.403 21.780 1.341
secretogranin III SCG3 0.020 0.720 0.500 21.401 21.255 1.125
Proprotein convertase subtilisin/kexin type 2 PCSK2 0.020 0.232 0.146 21.399 21.280 1.243
Programmed cell death 8 (apoptosis-inducing factor) PDCD8 0.020 0.856 0.017 21.397 21.507 1.265
tripartite motif-containing 44 TRIM44 0.020 0.943 0.017 21.387 22.430 1.201
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B,
gamma)
AKT3 0.020 0.880 0.017 21.385 21.155 1.475
reticulon 4 receptor-like 1 RTN4RL1 0.020 0.959 0.288 21.378 21.369 1.187
WD repeat domain 32 WDR32 0.140 0.959 0.057 21.378 21.364 1.324
zinc finger, DHHC-type containing 4 ZDHHC4 0.020 0.639 0.146 21.370 21.995 1.181
karyopherin alpha 6 (importin alpha 7) KPNA6 0.090 0.959 0.017 21.362 21.452 1.370
tribbles homolog 1 (Drosophila) TRIB1 0.279 0.534 0.017 21.359 21.758 1.519
calmodulin regulated spectrin-associated protein 1 CAMSAP1 0.020 0.534 0.017 21.351 21.267 1.453
member RAS oncogene family RAB22A 0.020 0.524 0.057 21.345 21.766 1.303
Calumenin CALU 0.035 0.856 0.039 21.344 21.923 1.292
Table 1. cont.
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HEPIS LOC119710 0.020 0.775 0.146 21.342 21.443 1.152
Ankyrin repeat domain 6 ANKRD6 0.140 0.943 0.098 21.341 21.361 1.220
kelch repeat and BTB (POZ) domain containing 7 KBTBD7 0.020 0.537 0.017 21.327 21.548 1.226
Rho-associated, coiled-coil containing protein kinase 2 ROCK2 0.020 0.232 0.120 21.323 21.773 1.289
dynactin 4 (p62) DCTN4 0.090 0.375 0.028 21.320 21.306 1.317
UDP-glucuronate decarboxylase 1 UXS1 0.279 0.232 0.017 21.315 21.943 1.558
chromosome 1 open reading frame 21 C1orf21 0.020 0.599 0.017 21.307 21.326 1.259
proliferation-associated 2G4, 38 kDa PA2G4 0.090 0.775 0.028 21.303 21.761 1.186
isocitrate dehydrogenase 2 (NADP+), mitochondrial IDH2 0.965 0.720 0.057 21.300 21.538 1.292
ring finger protein 41 RNF41 0.140 0.375 0.057 21.299 22.333 1.286
ATPase, aminophospholipid transporter-like, Class I, type 8A, member 2 ATP8A2 0.035 0.720 0.949 21.296 22.771 1.272
zinc finger protein 697 ZNF697 0.279 0.524 0.057 21.295 21.543 1.193
makorin, ring finger protein, 1 MKRN1 0.020 0.537 0.500 21.295 21.224 1.085
eukaryotic translation initiation factor 3, subunit 12 EIF3S12 0.020 0.501 0.120 21.294 22.174 1.187
transforming, acidic coiled-coil containing protein 1 TACC1 0.035 0.537 0.017 21.288 21.945 1.968
THUMP domain containing 3 THUMPD3 0.090 0.639 0.098 21.285 21.648 1.175
mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) MED8 0.020 0.438 0.193 21.282 21.376 1.131
Casein kinase 2, alpha 1 polypeptide CSNK2A1 0.020 0.959 0.098 21.279 21.367 1.572
metastasis associated 1 family, member 3 MTA3 0.390 0.959 0.017 21.276 21.299 1.268
DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 DDX54 0.965 0.959 0.017 21.272 21.272 1.322
Ras-associated protein Rap1 RBJ 0.020 0.856 0.949 21.270 21.325 1.131
cleavage stimulation factor, 39 pre-RNA, subunit 3, 77 kDa CSTF3 0.020 0.534 0.146 21.268 21.145 1.472
N-myristoyltransferase 1 NMT1 0.090 0.943 0.017 21.262 21.174 1.340
Component of oligomeric golgi complex 1 COG1 0.035 0.959 0.017 21.258 21.685 1.659
SERPINE1 mRNA binding protein 1 SERBP1 0.035 0.943 0.240 21.257 21.303 1.143
kelch domain containing 3 KLHDC3 0.140 0.720 0.193 21.252 21.255 1.194
zinc finger protein 436 ZNF436 0.195 0.232 0.193 21.249 21.379 1.122
KIAA1217 KIAA1217 0.965 0.639 0.240 21.247 21.953 1.328
sideroflexin 4 SFXN4 0.020 0.639 0.639 21.247 21.233 1.182
ankyrin repeat domain 28 ANKRD28 0.065 0.856 0.120 21.238 21.505 1.345
Phosphodiesterase 8B PDE8B 0.140 0.856 0.017 21.236 21.964 1.329
casein kinase 2, alpha prime polypeptide CSNK2A2 0.020 0.943 0.288 21.231 21.315 1.137
Ras association (RalGDS/AF-6) domain family 5 RASSF5 0.965 0.524 0.017 21.222 21.416 1.304
microfibrillar-associated protein 1 MFAP1 0.090 0.501 0.017 21.221 21.347 1.280
tRNA nucleotidyl transferase, CCA-adding, 1 TRNT1 0.065 0.537 0.288 21.219 21.673 1.137
golgi SNAP receptor complex member 2 GOSR2 0.390 0.959 0.639 21.216 21.404 1.545
v-ral simian leukemia viral oncogene homolog A (ras related) RALA 0.965 0.232 0.017 21.207 21.690 1.240
hypothetical protein FLJ11305 RP11-98F14.6 0.965 0.943 0.348 21.205 21.411 1.312
Zinc finger protein 291 ZNF291 0.279 0.943 0.017 21.205 21.342 1.458
UDP-N-acetyl-alpha-D-galactosamine (GalNAc-T2) GALNT2 0.390 0.537 0.017 21.202 21.155 1.388
Acyl-Coenzyme A dehydrogenase family, member 9 ACAD9 0.020 0.232 0.017 21.185 21.364 1.403
deltex 4 homolog (Drosophila) DTX4 0.020 0.599 0.017 21.180 21.254 1.314
casein kinase 1, gamma 1 CSNK1G1 0.279 0.856 0.017 21.169 21.430 1.274
KIAA1698 protein KIAA1698 0.279 0.534 0.017 21.157 21.405 1.380
Yip1 domain family, member 3 YIPF3 0.965 0.599 0.017 21.143 21.703 1.540
Adducin 3 (gamma) ADD3 0.065 0.599 0.085 1.540 1.329 21.289
III. Aging Genes that Diverged Between Rhesus Monkeys and Humans
cell division cycle 42 (GTP binding protein, 25 kDa) CDC42 0.020 0.524 0.017 21.688 1.608 1.186
melanoma antigen family H, 1 MAGEH1 0.020 0.232 0.776 21.504 1.697 1.203
Table 1. cont.
Evolution of the Aging Brain
PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3329cells derived from primary human cortical cultures, as previously
described [16]. For each set of genes enriched in a specific cell type
in mice, we determined the median fold enrichment in each of the
three human cell type arrays. Genes that were predicted to be
enriched in astrocytes and neurons in the mouse brain by the Allen
database were also enriched in the corresponding cell types
derived from the human cortex (Fig. S1 and Table S7).
The agreement between the human and mouse cell-type
enrichment datasets enabled us to use the Allen Brain Atlas to
localize age-related gene expression changes in both species. The
limited number of age-related changes in the rhesus dataset
prevented us from conducting a comprehensive cell type analysis
in rhesus macaques. To determine whether there is a relationship
between age-related expression changes and cell type localization,
we determined the number of age-related gene expression changes
thatcouldbelocalizedtoeachcelltypeusingtheAllenBrainAtlas.A
relationship between age-related expression changes and cell type
localization was analyzed statistically by determining if the number
of age-regulated genes enriched in specific cell types deviated
significantly from the number expected if these changes were
Figure 3. Cell type localization of gene expression in the aging cortex. Genes enriched in specific cortical cell types, based on the Allen Brain
Atlas, were analyzed in the aging mouse and human gene expression profiles. The percentage of age-regulated genes enriched in each cell type is
represented by the Y-axis was determined as described in Methods. The expected percentages are indicated by the dashed line. Statistically
significant cell type enrichment was determined using a Chi-square test with a permutation-based p-value (1,000 replicates). Specific cell types that
exhibit a statistically significant change in age-regulated genes are indicated by an asterisk.
doi:10.1371/journal.pone.0003329.g003
Gene Description Gene Symbol Q-Value (%) Fold Change
Human Rhesus Mouse Human Rhesus Mouse
Seryl-tRNA synthetase SARS 0.020 0.501 0.017 21.453 1.375 1.650
clathrin, heavy polypeptide (Hc) CLTC 0.020 0.375 0.057 21.438 1.056 1.207
E-1 enzyme MASA 0.020 0.524 0.949 21.323 1.618 1.158
F-box protein 28 FBXO28 0.020 0.232 0.146 21.301 1.701 1.155
abhydrolase domain containing 14A ABHD14A 0.390 0.501 0.017 21.192 1.318 1.404
eukaryotic translation initiation factor 1A, X-linked EIF1AX 0.740 0.232 0.146 21.175 2.762 1.278
hypothetical protein FLJ11155 FLJ11155 0.140 0.959 0.085 1.868 23.539 21.172
Shown are fold changes (aged to young intensity ratio; minus sign for age-downregulated, no sign for age-upregulated) and statistical q-values (%) derived by
Significance Analysis of Microarrays (SAM) as described in Methods. Category I contains genes for which age-related expression changes are conserved, both in terms of
significance and direction, across all three species. Category II contains genes in which the direction of the relationship with age changes from mouse to rhesus
macaque. Category III contains genes in which the direction of the relationship with age changes between rhesus macaque and human.
doi:10.1371/journal.pone.0003329.t001
Table 1. cont.
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localization analysis showed significant deviation from values
expected under the independence assumption (p-value,0.05).
Statistical significance was assessed using a Chi-squared test in
which thenulldistribution wasestimated based on 1,000 replications
(see Methods). The primary data and hypergeometric-based
estimates are provided in Tables S8 and S9, respectively. Both
humans and mice exhibit a larger fraction of age-upregulated
astrocyte- and oligodendrocyte-enriched genes, and age-downregu-
lated neuron-enriched genes, than would be expected by chance
alone (Fig. 3). However, relative to mice, human aging is
distinguished by a dramatic increase in the proportion of neuron-
enriched downregulated genes (Fig. 3). This was also observed when
the data wasstratified bygender (Text S2).Analysis of our data using
a different cell type transcriptome database, derived by isolation of
astrocytes, neurons and oligodendrocytes from transgenic mouse
cortex [17], confirmed that downregulation of neuronal genes
distinguishes aging humans from aging mice (data not shown).
As an independent line of evidence for age-related downregu-
lation of neuronal genes, we identified Gene Ontology (GO)
groups that were significantly enriched for age-related expression
changes (Table S10). In total, 24 neuronal GO groups were
significantly enriched for age-related expression changes in
humans (hypergeometric p-value,0.005) (Fig. 4a). In contrast,
only 5 of these 24 neuronal GO terms were slightly enriched for
genes significantly associated with age in mice (hypergeometric p-
value,0.05), despite similar or greater gene numbers for each GO
term represented on mouse versus human microarrays (Fig. 4b).
Further characterization of these GO terms revealed that the vast
majority of genes in the human-enriched neuronal GO terms were
downregulated with age. In contrast, the significant mouse neuronal
GO terms were primarily enriched for age-upregulated genes
(Fig. 4a). Thus, aging reduces the expression of genes with a variety
ofneuronalfunctions to a muchgreater extent inhumans than mice.
Age-Related Repression of Genes Involved in Inhibitory
Neurotransmission
Aging is associated with characteristic neurophysiologic and
cognitive changes attributable to specific neurotransmitter systems.
An important question, therefore, is whether age-related repres-
sion of neuronal genes selectively affects specific neurotransmitter
systems. We noted that the only significantly enriched GO groups
relating to a specific neurotransmitter were ‘‘GABA and GABA-A
receptor activity’’ (Fig. 4). To explore this finding further, we
examined the age-regulated expression of genes related to each of
the major cortical neurotransmitters, including glutamate, gam-
ma-aminobutyric acid (GABA), dopamine, glycine, serotonin, and
acetylcholine (Fig. 5a). The most robustly age-regulated group
corresponded to genes involved in GABA-mediated inhibitory
neurotransmission (Fig. 5a and Table S11). Multiple genes in this
category were age-downregulated with large fold changes in
humans, including GABA A receptor subunits alpha 1 (GABRA1),
alpha 5 (GABRA5), beta 3 (GABRB3) and gamma 2 (GABRG2),
the GABA vesicular transporter (SLC32A1), and the GABA
biosynthetic enzymes glutamate decarboxylase 1 and 2 (GAD1
and GAD2) (Table S11). Moreover, genes for the neuropeptides
calbindin 1 (CALB1), somatostatin (SST), vasoactive intestinal
peptide (VIP), cholecystokinin (CCK), tachykinin (TAC1), and
Figure 4. Neuronal gene ontology groups distinguish the expression profiles of the aging human and mouse cortex. a. Neuronal
gene ontology (GO) groups that are significantly enriched (p-value#0.005; binomial approximated p-value for a hypergeometric distribution) for age-
related expression changes (SAM comparison, FDR#0.01) were identified. The X-axis represents the percentage of genes in a GO group with age-
related up- or down-regulation. Multiple neuronal GO groups are enriched in the human aging profile; while only a few neuronal GO terms appear at
less significant thresholds in the mouse aging profile. Age-upregulated and age-downregulated genes are shown separately. b. Number of genes in
each GO group that are represented on the mouse and human microarray platforms.
doi:10.1371/journal.pone.0003329.g004
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subpopulations in prefrontal cortex, were significantly age-
downregulated (Fig. 5b). These genes were not significantly age-
downregulated in mice, although some inhibitory markers, such as
calbindin 1 and GABA A receptor subunit alpha 1, were
significantly age-downregulated in rhesus macaques (Fig. 5).
Downregulation of several glutamate-related genes, such as the
glutamate receptor subunits AMPA 1 (GRIA1) and kainate 1
(GRIK1), was also observed, but the number and magnitude of
these expression changes were less than that observed for GABA-
related genes (Fig. 5a and Table S11). A subset of these age-related
changes, notably calbindin 1, GABA A receptor subunit b3 and
AMPA 1, have been confirmed by quantitative real time RT-PCR
[6]. Thus, genes associated with inhibitory neurotransmission are
repressed in the aging human cortex.
Age-Related Reduction of Neuronal Proteins Is Not
Associated with Overall Neuronal or Synaptic Loss
To determine whether reduced mRNA levels are associated
with reduced protein levels in the aging brain, a subset of gene
products expressed in GABAergic neurons was examined by
quantitative Western blotting in cortical samples from young adult
and aged humans and mice. The protein level of the major GABA
biosynthetic enzyme in the brain, GAD1, was significantly reduced
in the aging human cortex, as well as the levels of calbindin 1 and
somatostatin, in agreement with the microarray data (Fig. 6a and
Fig. S2a). The neuropeptide VIP did not show a significant age-
related change at the protein level, in contrast to the age-related
reduction in VIP mRNA. This difference may reflect limited
sensitivity of the antibody used for Western blotting of VIP, or
post-translational regulation of VIP levels. In contrast to aging
human cortex, the aging mouse cortex did not exhibit altered
levels of calbindin or somatostatin, which is also in agreement with
the microarray data (Fig. 6b and Fig. S2b).
Stereological cell counting studies suggest that neuronal loss is
not significant in the aging human prefrontal cortex. To confirm
this finding, we performed quantitative Western blotting for two
established neuron-specific markers, b-tubulin III and neurofila-
ment L chain [17]. The levels of both proteins did not change
significantly in the aging human prefrontal cortex (Fig. 6a and Fig.
S2a). We also examined the presynaptic marker synaptophysin,
which did not show a significant age-related change in this cortical
region (Fig. 6a and Fig. S2a). These results suggest that
downregulation of neuronal genes in the aging human cortex
cannot be attributed to overall loss of neurons or synapses.
Discussion
We have compared the protein-coding transcriptome of the
aging cerebral cortex in mice, rhesus monkeys, and humans by
utilizing species-specific genome-scale microarrays. As such, this
study is not confounded by cross-species hybridization of RNA to
microarrays, and provides a broad view of the evolution of the
mammalian aging brain. Our results suggest that a relatively small
subset of age-regulated gene expression changes are conserved
from mouse to man. The most robustly age-upregulated of these
conserved genes is apolipoprotein D, which has been shown to
protect against oxidative stress and extend lifespan in Drosophila
Figure 5. Global repression of genes associated with GABA-mediated inhibitory neurotransmission. Shown are age-related changes in
the expression of genes that mediate major neurotransmitter systems in the cortex of humans, rhesus monkeys, and mice. a. Genes involved in
specific neurotransmitters were identified based on membership in the corresponding GO groups. Age-related fold changes in genes with orthologs
in all three species and represented on all three microarray platforms are shown for humans, rhesus monkeys, and mice. Gene identities are provided
in Table S11.
*q-value#0.01. b. Age-related fold changes for markers of inhibitory neuronal subpopulations. Statistical significance in a specific
species (q-value#0.01) is denoted with an asterisk.
doi:10.1371/journal.pone.0003329.g005
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level in the aging human brain and to a greater extent in a variety
of neurological diseases, including Alzheimer’s disease [20,21].
The most robustly age-downregulated gene conserved in all three
species is CAMK4, a key component of the cAMP signaling
cascade that links synaptic activity to CREB-dependent transcrip-
tion and modulates synaptic plasticity [14,22]. Another key cAMP
signaling gene, adenylate cyclase 2, is age-downregulated in
humans and rhesus macaques. Thus, increased expression of
neuroprotective genes and reduced expression of genes involved in
synaptic function are conserved features of mammalian aging.
Localization of gene expression by in situ hybridization and
analysis of gene ontology groups indicates that 3 cell types –
astrocytes, oligodendrocytes, and neurons – exhibit significant age-
dependent changes in gene expression in mice and humans.
However, age-related downregulation of neuronal genes has
increased dramatically from mouse to man, and is a major
distinguishing feature. Several lines of evidence suggest that this is
unlikely to be secondary to neuronal cell death. First, stereological
analysis of neuronal cell number did not detect neuronal loss in the
region of the aging human prefrontal cortex used in this study
[2,23]. Second, we have shown that expression of a number of
neuron-specific genes is unaltered in the aging human prefrontal
cortex at both the mRNA and protein levels. Moreover, the
absence of a significant age-related change in synaptophysin levels
suggests that overall synapse numbers may also be preserved.
However, this does not rule out more subtle changes in synaptic or
dendritic spine structure as reported in aging rhesus monkeys [24].
Finally, we showed previously that age-related gene downregula-
tion did not correlate with postmortem interval in the range used
in our study [6], consistent with the lack of an effect of postmortem
interval on RNA integrity in another study [25]. In addition, we
monitored brain tissue pH to exclude human cases with prolonged
terminal hypoxia [26]. Taken together, these findings are
consistent with a primary age-related change in the regulation of
neuronal gene expression. In a previous study, we found that
downregulated neuronal genes were associated with DNA damage
in the aging human cortex, and that DNA damage can repress the
transcription of these genes in primary neuronal cultures [6].
Another study suggested that some genes undergo age-dependent
DNA methylation [27]. Thus, transcriptional repression in
neurons may be a primary feature of human brain aging that
has evolved in long-lived primates.
A systematic investigation of genes involved in the major
cortical neurotransmitter systems suggests that the GABA system,
which mediates inhibitory neurotransmission, may be particularly
affected in the aging human prefrontal cortex. This is underscored
by the 50–60% reduction in mRNA and protein levels of GAD1,
the primary GABA biosynthetic enzyme in the brain. In addition,
the marked downregulation of calbindin 1 and somatostatin
suggests that specific inhibitory neuronal subpopulations may be
unusually vulnerable. Reduced calbindin 1 immunocytochemical
staining has also been demonstrated during normal brain aging in
rhesus monkeys and humans, and becomes more pronounced in
Alzheimer’s disease [28]. Thus, aging of the brain may be
associated with reduced inhibitory neurotransmission.
The central role of GABA in cognition and affective state raises
the possibility that age-dependent downregulation of this system
might contribute to neurophysiological and psychological changes in
the aging population [29]. Reduced inhibitory circuit activity might
increase cortical activation during the performance of routine
cognitive tasks, a phenomenon that has been demonstrated in the
aginghumanprefrontalcortexbyfunctionalimagingstudies[30,31].
This pattern of increased cortical activation may initially be
compensatory, enabling aged individuals to function at a higher
level [31]. However, increased excitation could predispose to
excitotoxicity, a mechanism of neuronal cell death associated with
a variety of age-related neurological disorders, including Alzheimer’s
disease [32]. Functional imaging studies have implicated cortical
overactivation due to impaired inhibitory function in patients with
Alzheimer’s disease [33]. The relevance of overexcitation to disease
pathogenesis is suggested by the clinical efficacy of the NMDA
receptor antagonist memantine, currently the only treatment that
delaysprogression ofmoderate tolate stage Alzheimer’s disease[34].
Interestingly, significant downregulation of GABA-related genes is
not detected in the aging mouse cortex, which may increase
resistance to excitotoxicity relative to aging humans. This may, in
turn, contribute to the paucity of neuronal cell death in mouse
models of neurodegenerative diseases compared with the human
pathology[2].Hence,a greaterunderstandingofnormal brainaging
and its evolution may provide new insights into pathogenic
mechanisms involved in age-related neurodegeneration.
Materials and Methods
Samples and Microarray Platforms
All aspects of animal housing and experimental procedures were
approved by the Institutional Animal Care and Use Committees of
Children’s Hospital Boston and the Beth Israel-Deaconess
Hospital (for rhesus macaques) and by the William S. Middleton
V.A. Medical Center and the University of Wisconsin-Madison
Figure 6. Reduced protein markers of inhibitory neurons in the
aged human cortex. a. GAD1, calbindin-1, and somatostatin protein
levels are significantly lower in the aged (71–91 yr; white) human cortex
than in the young adult (24–35 yr; black) cortex, in agreement with
microarray results. VIP expression is age-stable at the protein level. The
neuronal markers b-tubulin-III and neurofilament-L are age-stable at the
protein level, as is the synaptic protein synaptophysin. n=15. The
primary Western blot data are shown in Figure S2a. b. Calbindin-1,
somatostatin, and VIP protein levels are age-stable in the mouse cortex,
in agreement with the microarray results. Likewise, b-tubulin-III and
synaptophysin do not change significantly with age. Attempts to probe
for mouse GAD1 and neurofilament-L were not successful. n=6. The
primary Western blot data are shown in Figure S2b. In both a and b, the
level of each protein was normalized to the level of actin. Values
represent the mean6S.E.M. expressed as percent of the mean young
value for each protein. * P,0.05 by Student’s two-tailed t-test.
doi:10.1371/journal.pone.0003329.g006
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procured in accordance with institutional guidelines. Detailed
description of the human, rhesus macaque and murine samples
and extraction protocols are supplied in Text S1 and Table S1.
Postmortem human cortical samples were derived from subjects
that did not carry a diagnosis of Alzheimer’s disease or another
neurodegenerative disease, and showed neuropathological findings
within the normal range for age. In addition, human brain tissue
samples with a pH.6.5 were used to exclude prolonged terminal
hypoxia [26]. We generated genome-wide expression profiles of
young and aged cortical samples in humans, rhesus monkeys and
C57BL/6J mice using Affymetrix Human Genome U133plus 2.0
arrays, Rhesus Macaque Genome arrays and Mouse Genome 430
2.0 arrays, respectively. Affymetrix Human Genome U133plus 2.0
arrays were also used for expression profiling of neurons, microglia
and astrocytes isolated from primary fetal human cortical cultures.
Samples with acceptable parameters of RNA quality (Text S1)
were hybridized to the corresponding Affymetrix oligonucleotide
arrays, which were then scanned and expression data extracted
using the standard Affymetrix Microarray Suite Software.
Gene Mapping
Predicted rhesus macaque proteins, based on the Jan. 2006
version of the rhesus genome (Baylor College of Medicine HGSC
v1.0), were aligned to human Refseq protein sequences mapped to
NCBI Build 36 of the human genome. The mapping was
conducted using the BLAST program [35] by first creating a
BLAST protein database from the predicted rhesus proteins.
Using protein-BLAST, individual human Refseq proteins were
then compared to the rhesus protein database. A BLAST score
greater than 200, and at least 80% of the human protein aligning
to the predicted rhesus protein, was required to declare an
orthologous pair between the two species. A complete list of
orthologous human-rhesus gene pairs is provided in Table S2.
Expression Profiling and Analytical Approaches
To compare expression across species, genes were required to
have orthologs in the human, rhesus macaque and mouse genome
databases, and to have probesets in the microarray platforms for
each species. We also required that probes be called present using
dChip software in at least 20% of the arrays for each species. Four
approaches were used to analyze the genes meeting these criteria.
1. Significance Analysis of Microarrays (SAM) software was used
to compare young and aged groups within each species with the
following criteria for identifying age-related expression changes:
1000 permutations and median false discovery rate (FDR) #0.01.
Significant age-related gene expression changes are listed for
humans, rhesus macaques and mice in Tables S3, S4, and S5,
respectively. The subset of genes that are age-regulated in all three
species is provided in Table S6. These common age-related genes
were also resolved by hierarchical clustering using dChip software
(build date: April 11, 2007) [36]. The display range used in the
hierarchical clustering was 2.0 (a value greater than 2.0 standard
deviations above the mean is pure red, below is pure blue, and
equal to the mean is white). 2. Correlation coefficients between
samples were calculated and visualized using dChip software
across the 154 genes that are significantly associated with aging in
all three species. The range of observed correlation coefficients was
(20.78, 0.82), excluding a sample’s correlation with itself. The
display range used was 0.7 (correlation above 0.7 is pure red,
below is pure blue, and 0 is white). 3. The cell type enrichment
analysis of age-regulated genes was performed independently for
mice and humans, and included all genes that met the above
microarray criteria and were also present in the list of cell type-
enriched genes in the Allen Brain Atlas (Table S8). For the analysis
in humans, we required that the mouse ortholog to the human
gene be present in the list. For each species, the number of
significant age up- and down-regulated genes, as well as the
number of non-significant genes, was determined for each of the
five cell types indicated in the Allen Brain Atlas resulting in a 3-by-
5 table (Table S9). Assuming independence between cell types and
age-related expression changes, the expected count within each cell
of the table was estimated using the row and column totals. As a
result of the low count in some cells, a Monte Carlo p-value, based
on 1000 replications was calculated for each species to test whether
the observed count significantly deviated from what was expected by
chance.4.GeneOntologyanalysiswasperformed independentlyfor
humans and mice using dChip software (Table S10). A Gene
Ontology group is considered to be enriched in the aging database if
it contains a greater number of significantly age-related genes than
expected by chance. The statistical significance of GO group
enrichment is determined using a binomial approximation to the
hypergeometric distribution with a p-value cut-off of 0.005, as
described in detail elsewhere (www.dchip.org) [36].
Analysis of Cultured Human Cortical Cell Types
Neurons, astrocytes and microglia were isolated from primary
fetalhumancorticalculturesasdescribedpreviously[16].Expression
profiling of the isolated cortical cell types was performed using
Affymetrix U133 plus 2.0 arrays. To assess the concordance of gene
expression profiles of corresponding human and mouse cortical cell
types, we analyzed the probe sets on the human U133plus 2.0 arrays
that corresponded to the Allen Brain Atlas list of mouse cell type-
enriched genes (Table S7). Fold enrichment of a particular gene in a
specific human cell type was calculated as follows: the intensity of the
gene in one cell type was divided by the maximum of the intensities
in the two remaining cell types. The median fold enrichment of a
particular human cell type was then calculated over all of the genes
that were called enriched in a specific mouse cell type (Allen Brain
Atlas). The result was a human cell type enrichment score for every
human-mouse cell type combination (Fig. S1). Median fold values
greater than 1.0 indicated enrichment.
Western Blot Analysis
Human Brain. Postmortem human cortical tissue (Brodmann
area 9/10)was flashfrozen andstored at2150uuntiluse.Tissue was
homogenized in RIPA-DOC buffer containing protease inhibitors
(Complete, Roche) with microcystin (1 mm) and Na3Vo4 (1 mM).
Tissue was homogenized, sonicated, and centrifuged at 10,000 rpm
at 4uC and the protein concentration in the resulting supernatant
was assayed (BioRad protein assay). Samples were boiled in 16SDS
sample buffer containing DTT and resolved by 7% SDS-PAGE
using the Criterion System (BioRad) and electrotranferred to PVDF
membranes (Immobilon, Millipore). The primary antibodies and
dilutionsusedtoprobethePVDFmembranesaredescribedinTable
S12. Secondary antibodies (Jackson ImmunoResearch) were used at
1:2000 diluted in 5% nonfat milk. Blots were developed on film or
with a gel documentation system (Syngene) and quantified with
GeneTools software (Syngene).
Mouse Brain. Three young B6C3F1 mice (5 months) and
three aged B6C3F1 mice (30 months) were sacrificed and the
cortex was isolated and homogenized in 20 mM HEPES, 125 mM
NaCl, 0.1% NP40, 0.1% Triton X-100, 1 mM EDTA, 10 mM
nicotinamide, 1 mM trichostatin A, protease inhibitors (Complete,
Roche), and phosphatase inhibitors (PhosSTOP, Roche). Samples
were boiled in SDS sample buffer containing DTT, resolved by
SDS-PAGE on 10% or 12.5% Tris-glycine gels and
electrotransferred to PVDF membranes.
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